Featured Research

from universities, journals, and other organizations

Therapeutic fecal transplant: Hope for cure of childhood diarrhea comes straight from the gut

Date:
July 29, 2013
Source:
Johns Hopkins Medicine
Summary:
Call it therapeutic poop, if you will, but the best hope yet for an effective treatment of childhood infections with the drug-resistant bacterium C. difficile may come straight from the gut, according to recent research. This is why pediatric gastroenterologists are launching a fecal transplantation program for patients with recurrent diarrhea caused by what they say is a wily pathogen that is increasingly impervious to drugs and a rapidly growing problem among children and adults.

Call it therapeutic poop, if you will, but the best hope yet for an effective treatment of childhood infections with the drug-resistant bacterium C. difficile.may come straight from the gut, according to recent research. This is why pediatric gastroenterologists at the Johns Hopkins Children's Center are launching a fecal transplantation program for patients with recurrent diarrhea caused by what they say is a wily pathogen that is increasingly impervious to drugs and a rapidly growing problem among children and adults.

Related Articles


Over the last 20 years, cases of antibiotic-associated diarrhea have more than doubled, with nearly three million new infections each year, with up to a fourth of patients not responding to antibiotics, research shows. Most such cases, the researchers say, stemmed from infections with C. difficile.

Enter poop transplants. Studies in adults show that more than 90 percent of patients are cured following such therapy and, experts say, they have every reason to believe the numbers would be equally impressive in children.

"Fecal transplantation -- or the transfer of 'good' bacteria from the colon of one person into the colon of another -- should be considered for all children with C. diff infections who don't respond to two standard courses of antibiotics," says Maria Oliva-Hemker, M.D., director of pediatric gastroenterology at Johns Hopkins Children's Center.

The rise in refractory C. difficile infections has been fueled by the growing use of antibiotics, experts say.

"Antibiotics are lifesavers, but anytime we give them to a patient to eradicate one pathogen, there's collateral damage, in that along with the bad bacteria we wipe off some good organisms that help keep the complex workings of our gut in perfect balance," Oliva-Hemker says.

Such beneficial bacteria work by keeping rogue players in check, Oliva-Hemker explains, so any shifts in gut environment -- such as ones caused by antibiotics -- can have dire consequences. When good bacteria are killed off by antibiotics, the bad guys multiply causing an imbalance or "dysbiosis," Oliva-Hemker says. Typically, gut infections caused by one antibiotic are treated with another one to eradicate the overgrowth of harmful pathogens, but drugs often fail to do so fully or permanently because they only treat part of the problem.

"When we administer an antibiotic to treat the C. diff infection, we destroy some of the bad bacteria, but that does not address the other half of the problem -- the loss of good bacteria that might have led to the infection to begin with, so we never truly restore the balance in the gut and often the diarrhea returns with a vengeance in a matter of weeks," says Suchitra Hourigan, M.D., a pediatric gastroenterology fellow at Hopkins with a special interest in fecal transplantation.

The concept of treating poop woes with poop is hardly new. The method originated with ancient Chinese healers who gave their diarrhea-ravaged patients "yellow soup," a concoction of fecal matter and water. Thousands of years later, the delivery approach has evolved. Nowadays, fecal transplants are often performed during a colonoscopy, and improvement can be seen in as short as two weeks, as beneficial bacteria start to repopulate the patient's gut, Hourigan says. Fecal donors, usually parents or relatives, are carefully screened for risks much like any blood donor, Hourigan says. The donor's blood is tested for infectious pathogens, such as HIV and hepatitis C. People with autoimmune diseases or other chronic conditions, such diabetes or obesity, may not qualify as donors.

"The gut microbiome plays a major role in immunity and overall health, and right now we simply do not know whether fecal matter can somehow inadvertently also transfer the propensity toward such disorders from donor to recipient," Hourigan says.

The new pediatric protocol makes Johns Hopkins Children's Center one of a handful of pediatric hospitals in the country to offer this therapy for a condition that can cause dehydration, anemia and pain, and can seriously affect a child's quality of life, leading to absence from school. In its more extreme form, recurrent diarrhea can cause life-threatening colon inflammation, which is for some 14,000 deaths each year, according to the Centers for Disease Control and Prevention. Beyond the human toll, refractory diarrhea drains the health care system of more than $3 billion each year, research has shown.

Its great therapeutic success notwithstanding, some important questions remain: How precisely do donor bacteria change the recipient's gut microbiota and which bacteria make the best poop transplants? And because poop contains trillions of bacteria and hundreds of bacterial species, scientists have not quite figured out which ones are our best friends and worst foes and which ones are mere bystanders. These are some of the questions Oliva-Hemker and Hourigan's ongoing research is attempting to answer.

And with the growing understanding of gut dynamics, better therapies should emerge. In a decade or so, Oliva-Hemker predicts, scientists would be able to design the perfect fecal concoction in a lab, obviating the need for fecal transplants.

"In less than a decade, we'll have lab-cooked poop that we can administer to restore balance in the guts of people with a wide array of conditions caused by the imbalance between good and bad germs."


Story Source:

The above story is based on materials provided by Johns Hopkins Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medicine. "Therapeutic fecal transplant: Hope for cure of childhood diarrhea comes straight from the gut." ScienceDaily. ScienceDaily, 29 July 2013. <www.sciencedaily.com/releases/2013/07/130729133002.htm>.
Johns Hopkins Medicine. (2013, July 29). Therapeutic fecal transplant: Hope for cure of childhood diarrhea comes straight from the gut. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2013/07/130729133002.htm
Johns Hopkins Medicine. "Therapeutic fecal transplant: Hope for cure of childhood diarrhea comes straight from the gut." ScienceDaily. www.sciencedaily.com/releases/2013/07/130729133002.htm (accessed November 1, 2014).

Share This



More Plants & Animals News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Watch Baby Goose Survive A 400-Foot Cliff Dive

Watch Baby Goose Survive A 400-Foot Cliff Dive

Buzz60 (Oct. 31, 2014) For its nature series Life Story, the BBC profiled the barnacle goose, whose chicks must make a daredevil 400-foot cliff dive from their nests to find food. Jen Markham has the astonishing video. Video provided by Buzz60
Powered by NewsLook.com
World's Salamanders At Risk From Flesh-Eating Fungus

World's Salamanders At Risk From Flesh-Eating Fungus

Newsy (Oct. 31, 2014) The import of salamanders around the globe is thought to be contributing to the spread of a deadly fungus. Video provided by Newsy
Powered by NewsLook.com
Alcoholic Drinks In The E.U. Could Get Calorie Labels

Alcoholic Drinks In The E.U. Could Get Calorie Labels

Newsy (Oct. 31, 2014) A health group in the United Kingdom has called for mandatory calorie labels on alcoholic beverages in the European Union. Video provided by Newsy
Powered by NewsLook.com
Malaria Threat in Liberia as Fight Against Ebola Rages

Malaria Threat in Liberia as Fight Against Ebola Rages

AFP (Oct. 31, 2014) Focus on treating the Ebola epidemic in Liberia means that treatment for malaria, itself a killer, is hard to come by. MSF are now undertaking the mass distribution of antimalarials in Monrovia. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Plants & Animals

Earth & Climate

Fossils & Ruins

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins